Implant Sciences sells explosives detection equipment to Chinese airport
Implant Sciences Corporation sold seven Quantum Sniffer(TM) QS-H150 portable explosives trace detectors to an airport in China.
Implant Sciences said on Feb. 28, it continues to penetrate the China security market, having sold several million dollars worth of its QS-H150 there since 2008, to a large number of customers, including the Civil Aviation Administration of China.
Quoting the China Daily, the company said, between 2011 and 2015, China plans to expand as many as 91 of its existing 175 airports, while adding 56 new and potentially relocating 16 others. Implant Science said its distribution channels are well positioned to share in this growth, as well as growth in the rail and subway markets. This most-recent sale was made through the Company's Beijing-based distributor Beijing JingAnLanDun Science and Technology Development Co., Ltd, it said.
"Aviation security continues to be an important market for us in China," stated Implant Sciences' President and Chief Executive Glenn Bolduc. "The QS-H150's quality, functionality, performance, and low cost-of-use consistently win contracts even when going up against companies that are larger than us with far greater resources. We also see significant opportunity in the aviation security market with our newest product offering, the QS-B220."
The Quantum Sniffer QS-H150 is a handheld explosives trace detector that uses Ion Mobility Spectrometry (IMS) to rapidly detect and identify trace amounts of a wide variety of military, commercial, and homemade explosives. The QS-H150 uses no radioactive materials and features a low-maintenance design that is self-calibrating and self-clearing, providing very high levels of operational availability.
About the Quantum Sniffer QS-B220, introduced in May 2011, is a benchtop explosives and narcotics trace detector that uses Ion Mobility Spectrometry (IMS) to rapidly detect and identify trace amounts of a wide variety of military, commercial, and homemade explosives, plus narcotic substances. The QS-B220 continues the Implant Sciences tradition of freedom from radioactive materials, low total cost of ownership, and high operational availability.